Exact Mass: 480.1158436

Exact Mass Matches: 480.1158436

Found 50 metabolites which its exact mass value is equals to given mass value 480.1158436, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Cefepime

(6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-[(1-methylpyrrolidinium-1-yl)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

C19H24N6O5S2 (480.1249534)

Cefepime is a fourth-generation cephalosporin antibiotic developed in 1994. Cefepime has an extended spectrum of activity against Gram-positive and Gram-negative bacteria, with greater activity against both Gram-negative and Gram-positive organisms than third-generation agents. Cefepime is usually reserved to treat severe nosocomial pneumonia, infections caused by multi-resistant microorganisms (e.g. Pseudomonas aeruginosa) and empirical treatment of febrile neutropenia. J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01D - Other beta-lactam antibacterials > J01DE - Fourth-generation cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic

Cryptocyanine

Quinolinium,1-ethyl-4-[3-(1-ethyl-4(1H)-quinolinylidene)-1-propen-1-yl]-, iodide (1:1)

C25H25IN2 (480.10623999999996)

D004396 - Coloring Agents > D002232 - Carbocyanines

Staphyloferrin A

C17H24N2O14 (480.1227484)

A D-ornithine derivative obtained by formal condensation of the terminal carboxy groups of two citric acid units with the two amino groups of D-ornithine.

(2-(4-((2-Chloro-4,4-difluoro-spiro(5H-thieno(2,3-C)pyran-7,4'-piperidine)-1'-yl)methyl)-3-methyl-pyrazol-1-yl)-3-pyridyl)methanol

{2-[4-({2-chloro-4,4-difluoro-4,5-dihydrospiro[piperidine-4,7-thieno[2,3-c]pyran]-1-yl}methyl)-3-methyl-1H-pyrazol-1-yl]pyridin-3-yl}methanol

C22H23ClF2N4O2S (480.11982320000004)

LY2940094 (BTRX-246040) is a potent, selective and orally available nociceptin receptor (NOP receptor) antagonist with high affinity (Ki=0.105 nM) and antagonist potency (Kb=0.166 nM). LY2940094 reduces ethanol self-administration in animal models[1].

ZINC8618231

C23H20ClF3N2O4 (480.10636260000007)

Cys Asp Asp Glu

(2S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-carboxypropanamido]-3-carboxypropanamido]pentanedioic acid

C16H24N4O11S (480.11622339999997)

Cys Asp Glu Asp

(2S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-carboxypropanamido]-4-carboxybutanamido]butanedioic acid

C16H24N4O11S (480.11622339999997)

Cys Glu Asp Asp

(2S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-4-carboxybutanamido]-3-carboxypropanamido]butanedioic acid

C16H24N4O11S (480.11622339999997)

Asp Cys Asp Glu

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-carboxypropanamido]-3-sulfanylpropanamido]-3-carboxypropanamido]pentanedioic acid

C16H24N4O11S (480.11622339999997)

Asp Cys Glu Asp

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-carboxypropanamido]-3-sulfanylpropanamido]-4-carboxybutanamido]butanedioic acid

C16H24N4O11S (480.11622339999997)

Asp Asp Cys Glu

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-carboxypropanamido]-3-sulfanylpropanamido]pentanedioic acid

C16H24N4O11S (480.11622339999997)

Asp Asp Glu Cys

(4S)-4-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-carboxypropanamido]-4-{[(1R)-1-carboxy-2-sulfanylethyl]carbamoyl}butanoic acid

C16H24N4O11S (480.11622339999997)

Asp Glu Cys Asp

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-4-carboxybutanamido]-3-sulfanylpropanamido]butanedioic acid

C16H24N4O11S (480.11622339999997)

Asp Glu Asp Cys

(4S)-4-[(2S)-2-amino-3-carboxypropanamido]-4-{[(1S)-2-carboxy-1-{[(1R)-1-carboxy-2-sulfanylethyl]carbamoyl}ethyl]carbamoyl}butanoic acid

C16H24N4O11S (480.11622339999997)

Glu Cys Asp Asp

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-4-carboxybutanamido]-3-sulfanylpropanamido]-3-carboxypropanamido]butanedioic acid

C16H24N4O11S (480.11622339999997)

Glu Asp Cys Asp

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-4-carboxybutanamido]-3-carboxypropanamido]-3-sulfanylpropanamido]butanedioic acid

C16H24N4O11S (480.11622339999997)

Glu Asp Asp Cys

(4S)-4-amino-4-{[(1S)-2-carboxy-1-{[(1S)-2-carboxy-1-{[(1R)-1-carboxy-2-sulfanylethyl]carbamoyl}ethyl]carbamoyl}ethyl]carbamoyl}butanoic acid

C16H24N4O11S (480.11622339999997)

Pinacyanol iodide

1,1-Diethyl-2,2-carbocyanine iodide

C25H25IN2 (480.10623999999996)

D004396 - Coloring Agents > D002232 - Carbocyanines

N,N-BIS(4-CHLOROPHENYL)-N,N-DIPHENYL-1,4-PHENYLENEDIAMINE

C30H22Cl2N2 (480.1159952)

Anticefepime

C19H24N6O5S2 (480.1249534)

N-[2-[(2-chloro-4,6-dinitrophenyl)azo]-5-(ethylamino)-4-(2-methoxyethoxy)phenyl]acetamide

C19H21ClN6O7 (480.1160186)

Eletriptan hydrobromide monohydrate

C22H29BrN2O3S (480.10821440000007)

(2r)-2-(2-{[(1r)-1-Carboxy-4-{[(3s)-3,4-Dicarboxy-3-Hydroxybutanoyl]amino}butyl]amino}-2-Oxoethyl)-2-Hydroxybutanedioic Acid

C17H24N2O14 (480.1227484)

N-[(7,8-dihydropterin-6-yl)methyl]-4-(beta-D-ribofuranosyl)aniline 5-phosphate(2-)

C18H21N6O8P-2 (480.1158436)

Carbocyanine

C25H25IN2 (480.10623999999996)

D004396 - Coloring Agents > D002232 - Carbocyanines

Kryptocyanine

C25H25IN2 (480.10623999999996)

D004396 - Coloring Agents > D002232 - Carbocyanines

N(2),N(5)-di-(1-oxo-3-hydroxy-3,4-dicarboxybutyl)-D-ornithine

C17H24N2O14 (480.1227484)

2,5-difluoro-N-[2-(4-morpholinylmethyl)-5,6,7,8-tetrahydro-[1]benzothiolo[2,3-d]pyrimidin-4-yl]benzenesulfonamide

C21H22F2N4O3S2 (480.1101326)

N,N-dimethyl-4-[[3-[3-(5-methyl-2-furanyl)-1,2,4-oxadiazol-5-yl]-1-piperidinyl]sulfonyl]benzenesulfonamide

C20H24N4O6S2 (480.1137204)

N-[4-chloro-3-(4-morpholinylsulfonyl)phenyl]-4-(2-oxolanylmethoxy)benzamide

C22H25ClN2O6S (480.11217800000003)

6-bromomelleolide F

C23H29BrO6 (480.1147394)

2-[(1S,3R,4aR,9aS)-1-(hydroxymethyl)-6-(methanesulfonamido)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(4-chlorophenyl)methyl]acetamide

C22H25ClN2O6S (480.11217800000003)

2-[(1R,3R,4aR,9aS)-1-(hydroxymethyl)-6-(methanesulfonamido)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(4-chlorophenyl)methyl]acetamide

C22H25ClN2O6S (480.11217800000003)

2-[(1R,3S,4aR,9aS)-1-(hydroxymethyl)-6-(methanesulfonamido)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(4-chlorophenyl)methyl]acetamide

C22H25ClN2O6S (480.11217800000003)

2-[(1S,3S,4aR,9aS)-1-(hydroxymethyl)-6-(methanesulfonamido)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(4-chlorophenyl)methyl]acetamide

C22H25ClN2O6S (480.11217800000003)

2-[(1S,3S,4aS,9aR)-1-(hydroxymethyl)-6-(methanesulfonamido)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(4-chlorophenyl)methyl]acetamide

C22H25ClN2O6S (480.11217800000003)

2-[(1S,3R,4aS,9aR)-1-(hydroxymethyl)-6-(methanesulfonamido)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(4-chlorophenyl)methyl]acetamide

C22H25ClN2O6S (480.11217800000003)

2-[(1R,3R,4aS,9aR)-1-(hydroxymethyl)-6-(methanesulfonamido)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(4-chlorophenyl)methyl]acetamide

C22H25ClN2O6S (480.11217800000003)

2-[(1R,3S,4aS,9aR)-1-(hydroxymethyl)-6-(methanesulfonamido)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(4-chlorophenyl)methyl]acetamide

C22H25ClN2O6S (480.11217800000003)

Yersiniabactin(1-)

C21H26N3O4S3- (480.1085376000001)

A monocarboxylic acid anion that is the conjugate base of yersiniabactin, obtained from the deprotonation of the carboxy group. It is the major species at pH 7.3.

cefepime

C19H24N6O5S2 (480.1249534)

A cephalosporin bearing (1-methylpyrrolidinium-1-yl)methyl and (2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetamido groups at positions 3 and 7, respectively, of the cephem skeleton. J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01D - Other beta-lactam antibacterials > J01DE - Fourth-generation cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic

(3r,10ar)-3-chloro-10a-{[(1r,3s)-3-chloro-2,2-dimethyl-6-methylidenecyclohexyl]oxy}-6,8-dihydroxy-2,2-dimethyl-3h-naphtho[2,3-b]pyran-5,10-dione

C24H26Cl2O6 (480.1106356)

2-[({1-carboxy-4-[(3,4-dicarboxy-1,3-dihydroxybutylidene)amino]butyl}-c-hydroxycarbonimidoyl)methyl]-2-hydroxybutanedioic acid

C17H24N2O14 (480.1227484)

(2s)-2-({[(1r)-1-carboxy-4-{[(3s)-3,4-dicarboxy-1,3-dihydroxybutylidene]amino}butyl]-c-hydroxycarbonimidoyl}methyl)-2-hydroxybutanedioic acid

C17H24N2O14 (480.1227484)

3,4,7-trihydroxy-16-(2-hydroxy-3,4-dimethoxyphenyl)-13-methyl-9-oxa-15-thia-10,13-diazatetracyclo[10.2.2.0¹,¹⁰.0³,⁸]hexadec-5-ene-11,14-dione

C21H24N2O9S (480.12024540000004)

2-({[(1r)-1-carboxy-4-[(3,4-dicarboxy-1,3-dihydroxybutylidene)amino]butyl]-c-hydroxycarbonimidoyl}methyl)-2-hydroxybutanedioic acid

C17H24N2O14 (480.1227484)

(1r,3s,4r,7r,8s,12s,16r)-3,4,7-trihydroxy-16-(2-hydroxy-3,4-dimethoxyphenyl)-13-methyl-9-oxa-15-thia-10,13-diazatetracyclo[10.2.2.0¹,¹⁰.0³,⁸]hexadec-5-ene-11,14-dione

C21H24N2O9S (480.12024540000004)

2,4-bis(acetyloxy)-5-cyano-7-hydroxy-3-methyl-6,11-dioxo-1h,2h,3h,4h-benzo[b]carbazol-1-yl acetate

C24H20N2O9 (480.11687500000005)

1-{[(6r,7r)-2-carboxylato-7-{[(2z)-1-hydroxy-2-(2-imino-3h-1,3-thiazol-4-yl)-2-(methoxyimino)ethylidene]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl}-1-methylpyrrolidin-1-ium

C19H24N6O5S2 (480.1249534)

(1s,2s,3s,4s)-2,4-bis(acetyloxy)-5-cyano-7-hydroxy-3-methyl-6,11-dioxo-1h,2h,3h,4h-benzo[b]carbazol-1-yl acetate

C24H20N2O9 (480.11687500000005)